Siberia's Vector virology institute has completed Phase II testing of a second potential Russian vaccine against COVID-19, as reported in This is Money.
"Today... the final group of 20 volunteers was released from hospital," state consumer safety watchdog Rospotrebnadzor said.
It added that "all 100 volunteers were vaccinated with two doses and have completed a 23-day monitoring period in hospital. The volunteers are feeling good."
To read more NewsPoints articles, click here.